Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
SCHAUMBURG, Ill., July 30, 2014 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced...
-
SCHAUMBURG, Ill., July 17, 2014 (GLOBE NEWSWIRE) -- In a release issued earlier today by Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), the time of the teleconference and webcast was 9 a.m. ET. The...
-
SCHAUMBURG, Ill., July 17, 2014 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced...
-
SCHAUMBURG, Ill., June 9, 2014 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leading specialty pharmaceutical company with an emphasis on the injectable market, has been ranked...
-
SCHAUMBURG, Ill., May 6, 2014 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with a specific emphasis on the injectable market, today...
-
SCHAUMBURG, Ill., April 23, 2014 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today...
-
SCHAUMBURG, Ill., April 21, 2014 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the reintroduction of Adenosine Injection, USP, an antiarrhythmic agent, now in improved...
-
SCHAUMBURG, Ill., April 2, 2014 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced...
-
SCHAUMBURG, Ill., March 31, 2014 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) will join the Chicago Innovation Awards, the Chicago region's foremost annual celebration of innovation,...
-
SCHAUMBURG, Ill., March 31, 2014 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Adenosine Injection, USP, a pharmacologic stress agent, in two...